Recently visited unit

Optional shares

name	Price (yuan)	Rise and fall
The following are popular stocks

Please check the self selected shares first Sign in

name	Price (yuan)	Rise and fall

Management of self selected shares

^_^ sign out

join remind View in APP

Huahai Pharmaceutical (600521.SH)

Questioning stocks

@change@

@changeP@

@now@

Limit: @ up_limit@

Limit: @ down_limit@

Suspension

@date@ @time@

Temporary suspension

Today:	@open@	Volume:	@volume@	Amplitude:	@swing@
Maximum:	@high@	Turnover:	@amount@	turnover rate:	@turnover@
Minimum:	@low@	Total Market Value:	@fixTotalShare@	P/B ratio:	@pb@
Received yesterday:	@preClose@	Circulation value:	@cvs@	P/E ratio^TTM ：	@pe@
Total share capital:	@zgb@	Circulating shares:	@ltgb@

Information mine:

The browser version is too low to view the multi null inversion

Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox 、 Google

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Time-sharing

Day K

Week K

Month K

K line

Reinstatement K line

Technical drawings

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Also concerned:

5th gear disc opening

Live broadcast of famous teachers

Commission ratio -- Abandonment --
Selling ⑤	--	--
Sell ④	--	--
Selling ③	--	--
Sell ②	--	--
Selling ①	--	--
deal	--
Buy ①	--	--
Buy ②	--	--
Buy ③	--	--
Buy ④	--	--
Buy ⑤	--	--
Outer disc -- Inner disc --

In case of a key big order, the main force may**

Quickly use level2 to view details>

Pen by pen

Large order

Price sharing

Time-sharing

time	Price (yuan)	Measurement (hand)	nature

time	Price (yuan)	Measurement (hand)	nature

Transaction price (yuan)	Trading volume (hand)	Proportion (%)

time	Transaction price (yuan)	Trading volume (hand)

Scan code subscription

Investment research report

Questioning stocks

Live broadcast of stock market

Product entry: Sina Finance APP - Stocks - Investment Research Report

Product entrance: Sina Finance APP - stock - free question

money flow

Main compass Indicator description

Main and retail investors' capital flow
	Main buy	Main sales	Purchase by retail investors	Retail sales
Amount (10000 yuan)	@mainIn@	@mainOut@	@retailIn@	@retailOut@
proportion	@mainInP@	@mainOutP@	@retailInP@	@retailOutP@

Loose bill

Small order

Large order

Extra large order

Net inflow of classified funds
	Loose bill	Small order	Large order	Extra large order
Net inflow (10000 yuan)	@r3_r_in@	@r2_r_in@	@r1_r_in@	@r0_r_in@
Proportion in the flow board	@r3_p_svs@	@r2_p_svs@	@r1_p_svs@	@r0_p_svs@
Proportion in turnover rate	@r3_p_turnover@	@r2_p_turnover@	@r1_p_turnover@	@r0_p_turnover@

research report

Company research

Industry research

Big V view

Huahai Pharmaceutical Stock Exchange

title click reply Final reply

[Huahai Pharmaceutical: Changxing Pharmaceutical, a subsidiary of Huahai Pharmaceutical, terminated coaching in Beijing Stock Exchange four hundred and eighty-nine zero 06-14 16:03
[Huahai Pharmaceutical: obtained epirubicin hydrochloride injection two hundred and eighty-one zero 06-13 16:46
[Huahai Pharmaceutical: obtained the drug registration of Resagilan Mesylate Tablets eight hundred and seven zero 05-29 15:46
[Huahai Pharmaceutical: its subsidiary Tomoxetine Hydrochloride Oral Solution one thousand two hundred and twelve zero 05-10 17:30
What is a good stock??? (Samsung Medical one thousand four hundred and thirty-eight one 05-10 08:35
What is a good stock??? (Samsung Medical one thousand four hundred and fifty four 05-10 08:11
The API sector has performed well in the past month and is expected to welcome Davis one thousand five hundred and twenty zero 05-07 14:26
[Huahai Pharmaceutical: subsidiary obtained HB00 for injection one thousand eight hundred and twenty-six zero 04-29 17:25

Loss 45% five hundred and seventy-one zero 04-25 11:33
[11.5 million idle raised funds temporarily used for replenishment one thousand eight hundred and seventy zero 04-19 16:48
[Huahai Pharmaceutical: the company and relevant personnel received the information from Zhejiang Securities Regulatory Bureau one thousand eight hundred and forty zero 04-19 16:41
[Huahai Pharmaceutical: the performance of the first quarter of 2024 is expected to increase by 55% one thousand seven hundred and thirty-seven zero 04-15 17:17
200 shares have been favored by the main force and have risen from time to time after being cut two thousand and one zero 04-10 13:34
I think Duohuahai Pharmaceutical (SH600521) [I two thousand and twenty-six zero 04-09 17:13
[Huahai Pharmaceutical: HB0017 (IL- two thousand three hundred and twenty-six zero 04-01 10:04
worthless goods four hundred and eighty-two zero 03-22 14:35

Company research

Hot data

Adjacent ranking

Top 10 in the industry

Financial ratios

Adjacent ranking

Top 10 in the industry

Investment rating of research institutions

In the last 60 days The comprehensive rating of Huahai Pharmaceutical (sh600521) is as follows:

Hot columns

Industry comparison

name	Price (yuan)

expand all Pack All

Investment instruments

Market trend

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

corporate name:

Zhejiang Huahai Pharmaceutical Co., Ltd

Main business:

R&D, production and sales of multi dosage generic drugs, biological drugs, innovative drugs and characteristic APIs

Telephone: 0576-85991096

Fax: 0576-85016010

Date of establishment: 2001-02-28

Listing date: 2003-03-04

Legal representative: Chen Baohua

general manager: Chen Baohua

Registered capital: 1466.76 million yuan

Issue price: 15.55 yuan

Latest total share capital: 1466755454 shares

Latest outstanding shares: 10000 shares

Segment: Shanghai and Shenzhen A-share Shanghai A-share Shangzheng Medicine Shanghai Stock Exchange Index Social security heavy position Fund position Equity incentive Pharmaceuticals Shanghai Stock Connect CSI 500 Shanghai Stock Connect Anda

Financial summary

2024-03

2023-12

2023-09

2023-06

2023-03

Earnings per share	0.1827 yuan	RMB 0.5602	0.4867 yuan	0.3837 yuan	0.1166 yuan
net asset value per share	5.4498 yuan	5.2861 yuan	5.2859 yuan	5.4192 yuan	5.0521 yuan
Net operating cash flow per share	RMB 0.5755	1.4955 yuan	0.9792 yuan	0.6008 yuan	0.2521 yuan
Return on net assets	3.35%	10.60%	9.21%	7.08%	2.31%
Undistributed profit per share	3.3696 yuan	3.1869 yuan	3.1124 yuan	3.2476 yuan	2.9786 yuan
Capital reserve per share	0.8816 yuan	0.8745 yuan	0.9093 yuan	0.9064 yuan	0.9023 yuan

Date of announcement	Allocation scheme
2023-06-27	10 Pairs 2.4 yuan
2022-07-07	10 pairs1 yuan
2021-06-04	10 pairs, 2 yuan
2020-06-02	10 pairings 2 yuan to 1 share
2018-05-17	10 pairings 2 yuan to 2 shares

Circulation shareholders

2024-03

2023-12

2023-11

Name of shareholders	Shareholding (%)	Increase or decrease
Chen Baohua	twenty-five point one four nine	Unchanged
Zhou Minghua	fifteen point three zero zero	Unchanged
HKSCC has	two point three seven seven	Overweight
Zhejiang Huahai Pharmaceutical Co., Ltd	one point two zero five	Overweight
People's Property Protection of China	zero point seven seven five	Overweight
Taizhou City Financial Investment	zero point six seven five	reduce one's shares in a listed company
Agricultural Bank of China shares	zero point six seven one	New progress
Linhai City Financial Investment	zero point six two four	Unchanged
Su Chunlian	zero point six zero zero	Unchanged
Shanghai Jiuming Investment Management Co., Ltd	zero point four eight four	New progress

Name of shareholders	Shareholding (%)	Increase or decrease
Chen Baohua	twenty-five point three two eight	Overweight
Zhou Minghua	fifteen point four zero nine	Unchanged
HKSCC has	one point seven four six	reduce one's shares in a listed company
Zhejiang Huahai Pharmaceutical Co., Ltd	one point zero one zero	Overweight
Taizhou City Financial Investment	zero point eight five six	Unchanged
People's Property Protection of China	zero point six nine eight	New progress
Linhai City Financial Investment	zero point six two eight	Unchanged
Su Chunlian	zero point six zero four	Unchanged
China Merchants Bank Co., Ltd	zero point five six four	reduce one's shares in a listed company
Cathay Pacific Fund - Agriculture	zero point five four nine	reduce one's shares in a listed company
Cathay Pacific Fund - Construction	zero point five four nine	reduce one's shares in a listed company

Name of shareholders	Shareholding (%)	Increase or decrease
Chen Baohua	twenty-five point one four one	Unchanged
Zhou Minghua	fifteen point four two eight	Unchanged
HKSCC has	two point two two one	reduce one's shares in a listed company
Taizhou City Financial Investment	zero point eight five seven	Unchanged
Zhejiang Huahai Pharmaceutical Co., Ltd	zero point seven three three	Unchanged
Linhai City Financial Investment	zero point six two nine	Unchanged
Su Chunlian	zero point six zero five	Unchanged
Cathay Pacific Fund - Agriculture	zero point five eight four	Unchanged
China Merchants Bank Co., Ltd	zero point five eight two	reduce one's shares in a listed company
Cathay Pacific Fund - Construction	zero point five seven one	New progress

user name:
Password:
	Record login status for one month
	Sign in Retrieve password Login Help Not yet a member of Sina? New User Registration

Huahai Pharmaceutical (600521.SH)

Investment research report

Live broadcast of stock market

money flow

Company Information

research report

Big V view

Company No

Huahai Pharmaceutical Stock Exchange

Company research

Hot data

Financial ratios

Investment rating of research institutions

Hot columns

Industry comparison

Investment instruments

Market trend

Company information

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

Financial summary

Dividend distribution

Circulation shareholders

Shareholding ratio of circulating shareholders